CVS Stock Analysis: Buy, Sell, or Hold?
CVS - CVS HEALTH CORPORATION
$101.57
0.27 (0.27%)
▲
5d:
+0.88%
30d:
+8.84%
90d:
+42.47%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Smart Money Distribution
None View Scanner →
Strength: 10.0/10
Get Alerted When CVS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CVS trades at premium valuation expecting 5.2% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: CVS trades at premium valuation expecting 5.2% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$130.23
Based on 8.4% avg growth
INTRINSIC VALUE TODAY
$80.86
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CVS is currently trading at $101.57, which is considered extended relative to its 30-day fair value range of $92.01 to $99.63. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.1) compared to its historical average (10.4). At these levels, the market is pricing in 5.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CVS is in a strong uptrend. The price is approaching resistance at $102.77. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CVS is in a strong uptrend. The price is approaching resistance at $102.77. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CVS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$92.01 -
$99.63
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
56.2%
Protect Your Profits
Holding CVS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($105.00)
- NEUTRAL: Trading at premium valuation - market expects 5.2% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$92.01 -
$99.63
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$89.42
Resistance Level
$102.77
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.08
Wall Street Target
$105.00
(+3.7%)
Revenue Growth (YoY)
6.1%
Earnings Growth (YoY)
63.1%
Profit Margin
0.7%
Valuation Premium vs History
+5.2% premium
PE vs Historical
12.1 vs 10.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.2%
(market-implied from PE analysis)
1-Year Target
$106.57
(+5%)
2-Year Target
$112.11
(+11%)
3-Year Target
$117.94
(+16%)
3-Yr Target (if PE normalizes)
(PE: 12→10)
PE COMPRESSION
$101.51
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 12.8%)
$261.88
(+159%)
Base:
(SPY PE: 12.1, Growth: 12.8%)
$145.29
(+43%)
Bear:
(PE: 10.3, Growth: 12.8%)
$123.50
(+22%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 43.12 | Current EPS (TTM): $2.28
Bull Case
$216.30
(+114%)
Analyst growth 100.0%, PE expands to 47.4
Base Case
$196.64
(+94%)
Market implied 100.0%, PE stable at 43.1
Bear Case
$66.86
(-34%)
Severe decline -20.0%, PE contracts to 36.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 4:52 PM ET
Data refreshes hourly during market hours. Next update: 5:52 PM
Data refreshes hourly during market hours. Next update: 5:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-24
Michael T. McCaul
BUY
2026-02-20
John Boozman
BUY
2026-01-29
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$410 | 55 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 55 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$416 | 58 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$302 | 59 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$61 | 59 HOLD |
Advanced CVS Option Strategies
Professional options setups generated by AI based on today's CVS price and gamma walls.
